These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28286901)

  • 1. The effects of microRNAs on glucocorticoid responsiveness.
    Wang H; Gou X; Jiang T; Ouyang J
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1005-1011. PubMed ID: 28286901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
    Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
    J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
    Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
    Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
    FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
    Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
    Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
    Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
    Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
    BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.
    van Galen JC; Kuiper RP; van Emst L; Levers M; Tijchon E; Scheijen B; Waanders E; van Reijmersdal SV; Gilissen C; van Kessel AG; Hoogerbrugge PM; van Leeuwen FN
    Blood; 2010 Jun; 115(23):4810-9. PubMed ID: 20354172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
    Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
    Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
    Bergeron BP; Diedrich JD; Zhang Y; Barnett KR; Dong Q; Ferguson DC; Autry RJ; Yang W; Hansen BS; Smith C; Crews KR; Fan Y; Pui CH; Pruett-Miller SM; Relling MV; Yang JJ; Li C; Evans WE; Savic D
    Leukemia; 2022 Oct; 36(10):2374-2383. PubMed ID: 36028659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    Meyer LK; Delgado-Martin C; Maude SL; Shannon KM; Teachey DT; Hermiston ML
    PLoS One; 2019; 14(7):e0220026. PubMed ID: 31318944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
    Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
    Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma.
    Kim J; Jeong D; Nam J; Aung TN; Gim JA; Park KU; Kim SW
    Gene; 2015 Mar; 558(1):173-80. PubMed ID: 25576220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid resistance in childhood leukemia.
    Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
    Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.
    Tessel MA; Benham AL; Krett NL; Rosen ST; Gunaratne PH
    Horm Cancer; 2011 Jun; 2(3):182-9. PubMed ID: 21761344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
    Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
    Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
    Lucafò M; Sicari D; Chicco A; Curci D; Bellazzo A; Di Silvestre A; Pegolo C; Autry R; Cecchin E; De Iudicibus S; Collavin L; Evans W; Decorti G; Stocco G
    Cancer Chemother Pharmacol; 2020 Sep; 86(3):361-374. PubMed ID: 32776229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.